1. Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT);Aksu;Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci.,2012
2. The problems with today’s pharmaceutical business--an outsider’s view;Kessel;Nat. Biotechnol.,2011
3. Implementing quality by design for biotech products: are regulators on track?;Luciani;mAbs,2015
4. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticalsbfor Human Use, Quality Risk Management Q9, 2006. Available at: 〈http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html〉.
5. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Pharmaceutical Quality Systems (Q10), 2008. Available at: 〈http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html〉.